Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
With inflation easing and rates hovering, a carefully balanced $200,000 portfolio can generate about $930 a month in ...
Lightstone opens access to 25,000+ multifamily units for accredited investors as rents rise in tight markets. The mov...
As the market eyes a 4.5% yield from the LQD ETF, investors should scrutinize BBB credit risk and rate sensitivity th...
Oracle is leaning into AI infrastructure with its database expertise, cloud platform, and data-center plans. This art...
A high-profile finale featuring Paul McCartney highlighted the financial calculus networks face as linear TV ad spend...
Intuitive Machines has captured investor attention as space missions gain traction. This guide breaks down the main d...
Li Auto's 2026 earnings outlook hinges on shipments, margins, and smart capital allocation. This deep dive breaks dow...
CoreWeave's backlog booming has caught the eye of investors eyeing AI infrastructure. This piece breaks down whether ...
Bitcoin tumbled to $59,000 last Friday, the lowest in months, sparking a debate among traders about whether a bottom ...
Analysts warn that social security faces insolvency by 2032, threatening to reduce guaranteed benefits for 70 million...